Light therapy vs. vitamin D cream for mouth white patches
Part of Cancer, Mouth & dental clinical trials.
This study tests whether a light-based treatment (photodynamic therapy) works better than a vitamin D cream (calcipotriol) for treating white patches in the mouth that could become cancer. Both treatments are applied directly to the patch.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a white patch in your mouth (oral leukoplakia) that's at least as big as a nickel (2 cm²).
- You must be over 18 years old.
- You have not had any treatment for this condition in the last 2 months (except general care).
- You have no current or past history of cancer, and your mouth patch does not show signs of severe cell changes on biopsy.
- You do not have a condition that makes you very sensitive to light (like certain genetic or skin disorders).
- You are not pregnant or nursing.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a cream containing coenzyme Q10 and curcumin can help treat a common mouth condition called oral leukoplakia (a white patch that can sometimes turn into cancer). It is for people with a specific type of white patch that is not severe and can be easily reached with a cream.
This trial tests a low-cost approach to find and treat early mouth cancers or precancerous spots using a special light-activated drug (photodynamic therapy). The goal is to destroy the abnormal cells while sparing healthy tissue.
This study looks at oral leukoplakia (persistent white patches in the mouth) to better predict which ones may develop into cancer. It uses a test based on specific immune and cancer-related markers to help estimate each person’s risk.
This trial studies whether a two-medicine diabetes drug combination can reduce or control risky early changes in certain mouth and throat lesions. You may be asked for small tissue samples (biopsies) before and after 12 weeks to see how the lesions respond.
This study tests if metformin — a medication commonly used for diabetes — can prevent oral leukoplakia from turning into cancer when applied as a mouth rinse and taken as a pill. It is for people with non-severe white patches in the mouth.
This Phase 2 trial studies pembrolizumab (an immune medicine) for leukoplakia and related abnormal mouth patches with moderate/severe pre-cancer changes. It aims to see whether the treatment can shrink or control the lesions when surgery or radiation isn’t an option.
Hear when a new Oral Leukoplakia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.